Dr. Seemant Chaturvedi, MD

Dr. Chaturvedi practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Chaturvedi's NPI, 1154369882, was assigned on June 3, 2006. Dr. Chaturvedi graduated from University of Connecticut School of Medicine in 1989. Dr. Chaturvedi holds Maryland license D0086192.

Dr. Chaturvedi's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Chaturvedi's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Chaturvedi is also affiliated with University of Maryland Rehabilitation & Orthopaedic Institute. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Chaturvedi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chaturvedi practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chaturvedi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Chaturvedi is licensed in Maryland.

CMS data shows 185 Medicare services from Dr. Chaturvedi across 6 procedure codes in 2024, for 110 Medicare patients. Medicare paid $13,692 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 110 Medicare patients who saw Dr. Chaturvedi in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chaturvedi's median patient age at 64, with 50% women.

In 2024, Dr. Chaturvedi wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $161 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chaturvedi for performance year 2024, reported as part of a group. Dr. Chaturvedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 198 papers to Dr. Chaturvedi, published from 2006 to 2025. 2022 was the busiest year, with 19. The most frequent topics are Stroke, Carotid Stenosis and Endarterectomy, Carotid. Dr. Chaturvedi has published most often in Neurology. Dr. Chaturvedi's most frequent co-authors are Fadar Oliver Otite, MD, SCM, Priyank Khandelwal, MD and Dheeraj Gandhi, MD.

Dmand AI links Dr. Chaturvedi to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Carotid Stenosis, Ischemic Stroke and Myocardial Infarction.

CMS Open Payments shows 95 general payments to Dr. Chaturvedi from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $10,417.

Dr. Chaturvedi graduated from University of Connecticut School of Medicine in 1989.